Lataa...
Fimasartan for Remodeling after Myocardial Infarction
An angiotensin receptor blocker (ARB) mitigates cardiac remodeling after myocardial infarction (MI). Here, we investigated the effect of fimasartan, a new ARB, on cardiac remodeling after MI. Sprague–Dawley rats were assigned into 3 groups: surgery only (sham group, n = 7), MI without (MI-only group...
Tallennettuna:
| Julkaisussa: | J Clin Med |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6463200/ https://ncbi.nlm.nih.gov/pubmed/30875971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8030366 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|